Viewing Study NCT07117851


Ignite Creation Date: 2025-12-24 @ 11:51 PM
Ignite Modification Date: 2026-01-24 @ 6:18 AM
Study NCT ID: NCT07117851
Status: RECRUITING
Last Update Posted: 2025-08-12
First Post: 2025-08-05
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: A Study of Disitamab Vedotin + Bicalutamide in HER2/AR-Positive Scrotal Paget's Disease
Sponsor: Fudan University
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Extramammary Paget Disease View
None Scrotum Disease View
Keywords: